Zhang Y - Search Results

1

SPARC expression and prognostic value in non-small cell lung cancer.

Huang Y, Zhang J, Zhao YY, Jiang W, Xue C, Xu F, Zhao HY, Zhang Y, Zhao LP, Hu ZH, Yao ZW, Liu QY, Zhang L. Huang Y, et al. Among authors: zhang l, zhang j, zhang y. Chin J Cancer. 2012 Nov;31(11):541-8. doi: 10.5732/cjc.012.10212. Epub 2012 Oct 10. Chin J Cancer. 2012. PMID: 23114088 Free PMC article.

2

[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ. Zhang L, et al. Among authors: zhang y. Ai Zheng. 2004 Nov;23(11 Suppl):1455-8. Ai Zheng. 2004. PMID: 15566656 Clinical Trial. Chinese.

3

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Among authors: zhang l. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

4

[Efficacy of erlotinib on advanced non-small cell lung cancer].

Zhao HY, Zhang Y, Huang H, Chen LK, Xu GC, Zhang L. Zhao HY, et al. Among authors: zhang l, zhang y. Ai Zheng. 2008 Apr;27(4):393-9. Ai Zheng. 2008. PMID: 18423126 Free article. Chinese.

5

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: zhang l, zhang y. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

6

[Predictive factors for response and survival of gefitinib-treated locally advanced or metastatic non-small cell lung cancer patients: a retrospective analysis of two phase II clinical trials].

Zhao YY, Zhang Y, Zhao HY, Wu JX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Among authors: zhang l, zhang y. Ai Zheng. 2009 Jun;28(6):626-31. Ai Zheng. 2009. PMID: 19635201 Free article. Chinese.

7

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib.

Wang F, Zhang Y, Zhao H, Chen L, Shi YX, Zhang L. Wang F, et al. Among authors: zhang l, zhang y. Med Oncol. 2011 Mar;28(1):331-5. doi: 10.1007/s12032-010-9451-1. Epub 2010 Mar 4. Med Oncol. 2011. PMID: 20204544

8

The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib.

Zhao YY, Li S, Zhang Y, Zhao HY, Liao H, Guo Y, Shi YX, Jiang W, Xue C, Zhang L. Zhao YY, et al. Among authors: zhang l, zhang y. Med Oncol. 2011 Sep;28(3):697-702. doi: 10.1007/s12032-010-9541-0. Epub 2010 May 11. Med Oncol. 2011. PMID: 20458561 Clinical Trial.

9

[A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].

Hu X, Bao Y, Zhang L, Cheng Y, Li K, Wang W, Liu Y, He H, Sun Z, Zhuang T, Wang Y, Chen J, Liang Y, Zhang Y, Zhao H, Wang F, Chen M. Hu X, et al. Among authors: zhang l, zhang y. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):691-9. doi: 10.3779/j.issn.1009-3419.2010.07.07. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673485 Free PMC article. Clinical Trial. Chinese.

10

[Immediate versus delayed topotecan after first-line therapy in small cell lung cancer].

Jiang W, Zhang Y, Zhao H, Xu G, Lin L, Zhao Y, Xue C, Zhang L. Jiang W, et al. Among authors: zhang l, zhang y. Zhongguo Fei Ai Za Zhi. 2010 Mar;13(3):211-5. doi: 10.3779/j.issn.1009-3419.2010.03.05. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673518 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259,757 results

Search Page

Filters